Qalyvis 0.25mcg
MAL Number:
MAL25046039X
Indications:
- Established postmenopausal osteoporosis.
- Renal osteodystrophy in patients with chronic renal failure, particularly those undergoing hemodialysis.
- Postsurgical hypoparathyroidism.
- Idiopathic hypoparathyroidism.
- Pseudohypoparathyroidism.
- Vitamin D-dependent rickets.
- Hypophosphatemic vitamin D-resistant rickets.
- Predialysis patients
Active Ingredient:
Calcitriol 0.25 mcg
Pack Size:
10 X 3 Capsules
Therapeutic Category: Agents Affecting Bone Metabolism
